Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Viruxo.com
WARNING LETTER
•Viruxo.com•April 28, 2011

Viruxo.com – FDA Warning Letter, Apr 28, 2011

Record Details

On April 28, 2011, the FDA and FTC issued a Warning Letter to Viruxo LLC, following a review of their website, www.viruxo.com. The product "Viruxo Anti-Viral Support" was found to be promoted with therapeutic claims, classifying it as an unapproved new drug under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)].

Violations included claims such as "New Herpes Treatment! Cure for Herpes Outbreaks," "Never Have A Herpes Outbreak Again!", and "America’s #1 Herpes Outbreak Eliminator!" These claims, along with others on the FAQ page and in customer testimonials, establish the product's intent for disease treatment or prevention. The product is also deemed misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] because it lacks adequate directions for use by a layperson for conditions not amenable to self-diagnosis. The introduction of this misbranded drug into interstate commerce violates § 301(a) of the Act [21 U.S.C. § 331(a)].

The FTC also cited violations of the FTC Act, 15 U.S

Company
Viruxo.com
Inspection date
April 28, 2011
Product type
Drugs
Office
Department of Health and Human Services
People
  • Emma R. Singleton (District Director)
  • Mary K. Engle (Associate Director)
  • William A. Correll (Director)
View Company Profile

ID · 1f352e53-c13f-43f2-b295-b259877b6b7c

Violation Codes5
21 U.S.C. 321(g)(1)(B)21 U.S.C. 352(f)(1)21 U.S.C. 321(p)21.U.S.C. 355(a)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Viruxo.com
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.